Pharmaceuticals

Eurofins expects this acquisition to significantly strengthen its capabilities and expertise in drug discovery.

According to leadership, Ferrari has a deep knowledge of SK's sectors of focus.

The board recommends that Urovant shareholders vote in favor of the merger at the upcoming special general meeting.